Elevation Historical Balance Sheet

ELEV Stock

USD 0.62 0.01 1.59%

Trend analysis of Elevation Oncology balance sheet accounts such as Total Current Liabilities of 7.9 M or Total Stockholder Equity of 47.4 M provides information on Elevation Oncology's total assets, liabilities, and equity, which is the actual value of Elevation Oncology to its prevalent stockholders. By breaking down trends over time using Elevation Oncology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevation Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.

About Elevation Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Elevation Oncology at a specified time, usually calculated after every quarter, six months, or one year. Elevation Oncology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Elevation Oncology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Elevation currently owns. An asset can also be divided into two categories, current and non-current.

Elevation Oncology Balance Sheet Chart

At this time, Elevation Oncology's Accumulated Other Comprehensive Income is fairly stable compared to the past year. Intangible Assets is likely to climb to 69.03 in 2024, whereas Net Tangible Assets are likely to drop slightly above 44.2 M in 2024.

Total Assets Other Current Liab Total Current Liabilities Accounts Payable

Total Assets

Total assets refers to the total amount of Elevation Oncology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Elevation Oncology books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Elevation Oncology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Elevation Oncology are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents Elevation Oncology obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Elevation Oncology are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from Elevation Oncology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Elevation Oncology current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elevation Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy Elevation Stock please use our How to Invest in Elevation Oncology guide.At this time, Elevation Oncology's Accumulated Other Comprehensive Income is fairly stable compared to the past year. Intangible Assets is likely to climb to 69.03 in 2024, whereas Net Tangible Assets are likely to drop slightly above 44.2 M in 2024.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	3.1M	9.3M	3.6M	3.8M
Total Assets	149.5M	94.2M	89.1M	91.4M

Other Current Liab Total Assets

Elevation Oncology balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Other Liab	Non Currrent Assets Other	Other Assets	Non Current Liabilities Other	Intangible Assets	Common Stock	Property Plant Equipment	Short Long Term Debt Total
Total Assets		0.73	0.84	0.85	0.85	-0.8	-0.71	0.74	0.96	1.0	0.35	0.41	0.94	0.57	0.51	0.87	1.0	1.0	-0.78	0.54	0.26	-0.78	0.15	0.41	0.55	0.37
Other Current Liab	0.73		0.94	0.61	0.61	-0.28	-0.8	0.65	0.52	0.72	0.27	0.26	0.65	0.76	0.39	0.73	0.73	0.69	-0.87	0.85	0.79	-0.87	0.75	0.32	0.8	0.3
Total Current Liabilities	0.84	0.94		0.64	0.63	-0.52	-0.69	0.84	0.72	0.84	0.11	0.43	0.69	0.59	0.56	0.71	0.84	0.81	-0.78	0.67	0.71	-0.78	0.61	0.17	0.62	0.29
Total Stockholder Equity	0.85	0.61	0.64		1.0	-0.72	-0.58	0.5	0.82	0.85	0.28	-0.13	0.93	0.58	-0.02	0.98	0.85	0.85	-0.71	0.41	0.17	-0.71	-0.03	0.34	0.43	0.27
Net Tangible Assets	0.85	0.61	0.63	1.0		-0.72	-0.58	0.5	0.82	0.84	0.29	-0.13	0.93	0.57	-0.02	0.98	0.85	0.85	-0.7	0.41	0.17	-0.7	-0.04	0.34	0.43	0.25
Net Debt	-0.8	-0.28	-0.52	-0.72	-0.72		0.17	-0.74	-0.93	-0.81	0.05	-0.32	-0.73	-0.01	-0.38	-0.63	-0.81	-0.82	0.27	0.04	0.05	0.27	0.34	0.0	0.02	0.0
Retained Earnings	-0.71	-0.8	-0.69	-0.58	-0.58	0.17		-0.26	-0.5	-0.7	-0.76	-0.27	-0.74	-0.96	-0.36	-0.72	-0.71	-0.7	0.98	-0.92	-0.33	0.98	-0.53	-0.79	-0.93	-0.68
Accounts Payable	0.74	0.65	0.84	0.5	0.5	-0.74	-0.26		0.73	0.75	-0.22	0.53	0.53	0.08	0.64	0.51	0.75	0.72	-0.36	0.27	0.58	-0.36	0.28	-0.18	0.22	-0.16
Cash	0.96	0.52	0.72	0.82	0.82	-0.93	-0.5	0.73		0.96	0.2	0.38	0.89	0.36	0.47	0.79	0.96	0.97	-0.58	0.27	0.07	-0.58	-0.1	0.25	0.29	0.31
Cash And Short Term Investments	1.0	0.72	0.84	0.85	0.84	-0.81	-0.7	0.75	0.96		0.34	0.41	0.94	0.56	0.51	0.87	1.0	1.0	-0.77	0.53	0.26	-0.77	0.14	0.39	0.54	0.36
Common Stock Shares Outstanding	0.35	0.27	0.11	0.28	0.29	0.05	-0.76	-0.22	0.2	0.34		0.19	0.52	0.72	0.18	0.4	0.35	0.37	-0.65	0.67	-0.21	-0.65	0.08	1.0	0.76	0.53
Non Current Liabilities Total	0.41	0.26	0.43	-0.13	-0.13	-0.32	-0.27	0.53	0.38	0.41	0.19		0.17	0.01	0.99	-0.06	0.41	0.4	-0.18	0.25	0.13	-0.18	0.24	0.19	0.25	0.14
Other Current Assets	0.94	0.65	0.69	0.93	0.93	-0.73	-0.74	0.53	0.89	0.94	0.52	0.17		0.66	0.27	0.95	0.94	0.95	-0.81	0.56	0.11	-0.81	0.01	0.57	0.6	0.38
Other Stockholder Equity	0.57	0.76	0.59	0.58	0.57	-0.01	-0.96	0.08	0.36	0.56	0.72	0.01	0.66		0.1	0.71	0.57	0.56	-0.96	0.9	0.34	-0.96	0.54	0.76	0.91	0.69
Total Liab	0.51	0.39	0.56	-0.02	-0.02	-0.38	-0.36	0.64	0.47	0.51	0.18	0.99	0.27	0.1		0.06	0.51	0.5	-0.29	0.34	0.25	-0.29	0.32	0.19	0.33	0.16
Net Invested Capital	0.87	0.73	0.71	0.98	0.98	-0.63	-0.72	0.51	0.79	0.87	0.4	-0.06	0.95	0.71	0.06		0.87	0.87	-0.82	0.59	0.28	-0.82	0.13	0.46	0.6	0.32
Total Current Assets	1.0	0.73	0.84	0.85	0.85	-0.81	-0.71	0.75	0.96	1.0	0.35	0.41	0.94	0.57	0.51	0.87		1.0	-0.78	0.54	0.26	-0.78	0.15	0.41	0.55	0.37
Net Working Capital	1.0	0.69	0.81	0.85	0.85	-0.82	-0.7	0.72	0.97	1.0	0.37	0.4	0.95	0.56	0.5	0.87	1.0		-0.76	0.51	0.21	-0.76	0.1	0.42	0.53	0.37
Other Liab	-0.78	-0.87	-0.78	-0.71	-0.7	0.27	0.98	-0.36	-0.58	-0.77	-0.65	-0.18	-0.81	-0.96	-0.29	-0.82	-0.78	-0.76		-0.9	-0.42	1.0	-0.53	-0.7	-0.9	-0.61
Non Currrent Assets Other	0.54	0.85	0.67	0.41	0.41	0.04	-0.92	0.27	0.27	0.53	0.67	0.25	0.56	0.9	0.34	0.59	0.54	0.51	-0.9		0.57	-0.9	0.73	0.7	0.99	0.41
Other Assets	0.26	0.79	0.71	0.17	0.17	0.05	-0.33	0.58	0.07	0.26	-0.21	0.13	0.11	0.34	0.25	0.28	0.26	0.21	-0.42	0.57		-0.42	0.86	-0.17	0.48	-0.15
Non Current Liabilities Other	-0.78	-0.87	-0.78	-0.71	-0.7	0.27	0.98	-0.36	-0.58	-0.77	-0.65	-0.18	-0.81	-0.96	-0.29	-0.82	-0.78	-0.76	1.0	-0.9	-0.42		-0.53	-0.7	-0.9	-0.61
Intangible Assets	0.15	0.75	0.61	-0.03	-0.04	0.34	-0.53	0.28	-0.1	0.14	0.08	0.24	0.01	0.54	0.32	0.13	0.15	0.1	-0.53	0.73	0.86	-0.53		0.11	0.64	0.23
Common Stock	0.41	0.32	0.17	0.34	0.34	0.0	-0.79	-0.18	0.25	0.39	1.0	0.19	0.57	0.76	0.19	0.46	0.41	0.42	-0.7	0.7	-0.17	-0.7	0.11		0.78	0.55
Property Plant Equipment	0.55	0.8	0.62	0.43	0.43	0.02	-0.93	0.22	0.29	0.54	0.76	0.25	0.6	0.91	0.33	0.6	0.55	0.53	-0.9	0.99	0.48	-0.9	0.64	0.78		0.43
Short Long Term Debt Total	0.37	0.3	0.29	0.27	0.25	0.0	-0.68	-0.16	0.31	0.36	0.53	0.14	0.38	0.69	0.16	0.32	0.37	0.37	-0.61	0.41	-0.15	-0.61	0.23	0.55	0.43

Click cells to compare fundamentals

Elevation Oncology Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elevation Stock Analysis

When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Elevation Historical Balance Sheet

About Elevation Balance Sheet Analysis

Elevation Oncology Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

Elevation Oncology balance sheet Correlations

Elevation Oncology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Elevation Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Net Working Capital	+ 1.0	Cash And Short Term Investments

Non Current Liabilities Other	- 0.96	Other Stockholder Equity
Other Liab	- 0.96	Other Stockholder Equity
Other Stockholder Equity	- 0.96	Retained Earnings
Property Plant Equipment	- 0.93	Retained Earnings
Cash	- 0.93	Net Debt
Non Currrent Assets Other	- 0.92	Retained Earnings